mechanisms. The company's research targets include receptors, ion channels, enzymes, and carrier molecules, with a significant emphasis on restoring DNA repair efficiency to prevent ageing-related conditions. Carpe Vitae Pharmaceuticals also explores the use of PARP inhibitors, a class of drugs known for their role in cancer treatment, by blocking the activity of PARP DNA repair enzymes. The company's mission revolves around improving the quality of life and extending the healthy years of life, aligning with modern medicine's goal to not just prolong life but enhance its quality.